Valproic Acid in Treating Patients With Progressive, Non-Metastatic Prostate Cancer
Stopped early · Phase 2
Conditions studied: Prostate Cancer
In brief
RATIONALE: Valproic acid may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. It is not yet known whether valproic acid is more effective than observation in treating patients with prostate cancer. PURPOSE: This randomized phase II trial is studying how well valproic acid works in treating patients with progressive, non-metastatic prostate cancer.
Key facts
- Study ID
- NCT00670046
- Run by
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- People needed
- 15
- Starts
- 2008-05-01
- Expected to finish
- 2012-07-01
- Last updated by the study team
- 2018-09-28
Who can join
Age: 18 and older, up to 85. Sex: male. Healthy volunteers: not accepted.
Where it is running
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins — Baltimore, Maryland, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.